Nvidia Corporation's FY25 revenue surged 114% YoY, driven by AI dominance and Blackwell architecture. Click for my updated ...

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline data of a ...

The Company expects topline results from ALTITUDE-AD, a Phase 2 study to investigate sabirnetug for the treatment of early Alzheimer’s disease, in late 2026. Easily identify stocks' risks and ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Rep. Rob Wittman (R-Va.), vice chair of the House Armed Services Committee, said he wants to see more resources pushed ...

CEBU-BASED fuel retailer Top Line Business Development Corp. (Topline) has secured approval from the Securities and Exchange ...

Topline Farms is bringing the Roma Revolution to the CPMA Convention & Trade Show in Montreal from April 8-10, 2025, at Booth #1715.

Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...

The entire 36-week data for the remaining subjects in the trial is anticipated in the second quarter of this year.

Topline data indicate that REFOCUS-ALZ did not meet each of the prespecified co-primary, secondary and exploratory biomarker endpoints. The co-primary endpoints were the change in cognition and ...